Pacira Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Pacira BioSciences,
PCRX Stock  USD 16.64  0.14  0.83%   
Pacira BioSciences, financial statements provide useful quarterly and yearly information to potential Pacira BioSciences, investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Pacira BioSciences, financial statements helps investors assess Pacira BioSciences,'s valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pacira BioSciences,'s valuation are summarized below:
Gross Profit
393.2 M
Profit Margin
(0.13)
Market Capitalization
774.8 M
Enterprise Value Revenue
1.3798
Revenue
695 M
We have found one hundred twenty available trending fundamental ratios for Pacira BioSciences,, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Pacira BioSciences, recent market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 1.7 B in 2024. Enterprise Value is likely to rise to about 1.8 B in 2024

Pacira BioSciences, Total Revenue

708.73 Million

Check Pacira BioSciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 15.8 M or Selling General Administrative of 63.1 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0014 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences, Valuation or Volatility modules.
  
Check out the analysis of Pacira BioSciences, Correlation against competitors.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

Pacira BioSciences, Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.7 B1.6 B797.4 M
Slightly volatile
Other Current Liabilities41.2 M64.2 M42.3 M
Slightly volatile
Total Current Liabilities123.5 M97.4 M125.9 M
Slightly volatile
Total Stockholder Equity913.6 M870.1 M375.7 M
Slightly volatile
Other Liabilities24.9 M43.5 M23.8 M
Slightly volatile
Property Plant And Equipment Net120.3 M234.9 M121.8 M
Slightly volatile
Current Deferred Revenue41.1 M39.1 M24 M
Slightly volatile
Accounts Payable10.4 M15.7 M9.9 M
Slightly volatile
Cash117.4 M153.3 M119.5 M
Slightly volatile
Non Current Assets Total1.1 B1.1 B442.8 M
Slightly volatile
Non Currrent Assets Other37.9 M36 M18.3 M
Slightly volatile
Other Assets0.951.041 M
Slightly volatile
Cash And Short Term Investments237.8 M278.6 M244.2 M
Slightly volatile
Net Receivables110.8 M105.6 M45.5 M
Slightly volatile
Common Stock Total Equity32.8 K51.8 K36.4 K
Slightly volatile
Common Stock Shares Outstanding35.9 M52 M36 M
Slightly volatile
Short Term Investments137.9 M125.3 M142.8 M
Slightly volatile
Liabilities And Stockholders Equity1.7 B1.6 B797.4 M
Slightly volatile
Non Current Liabilities Total637.2 M606.9 M297.1 M
Slightly volatile
Inventory109.6 M104.4 M51.6 M
Slightly volatile
Other Current Assets22.6 M21.5 M11.5 M
Slightly volatile
Other Stockholder Equity599.8 M976.6 M609.2 M
Slightly volatile
Total Liabilities396.5 M704.3 M398.8 M
Slightly volatile
Property Plant And Equipment Gross388.8 M370.3 M148.7 M
Slightly volatile
Total Current Assets331.8 M510 M341 M
Slightly volatile
Short Term Debt16.6 M17.4 M71.2 M
Pretty Stable
Intangible Assets507.4 M483.3 M172.4 M
Slightly volatile
Common Stock35.1 K52.9 K36.7 K
Slightly volatile
Property Plant Equipment307.2 M292.5 M130.6 M
Slightly volatile
Short and Long Term Debt Total348.5 M586 M318.9 M
Slightly volatile
Long Term Debt Total240.7 M360 M199.6 M
Slightly volatile
Capital Surpluse685.2 M1.1 B627.3 M
Slightly volatile
Non Current Liabilities Other36 M38.3 M27.8 M
Slightly volatile
Short and Long Term Debt8.2 M8.6 M62.6 M
Slightly volatile
Net Invested Capital1.1 B1.4 B785.4 M
Slightly volatile
Net Working Capital402.2 M412.6 M353.7 M
Slightly volatile
Capital Stock48.4 K52.9 K43.2 K
Slightly volatile
Capital Lease Obligations75.1 M63.6 M55.3 M
Slightly volatile

Pacira BioSciences, Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization79.4 M75.6 M25.4 M
Slightly volatile
Interest Expense15.8 M20.3 M15.8 M
Slightly volatile
Selling General Administrative63.1 M116.4 M61.7 M
Slightly volatile
Total Revenue708.7 M675 M329 M
Slightly volatile
Other Operating Expenses616.7 M587.3 M312.5 M
Slightly volatile
Research Development46.7 M76.3 M45.4 M
Slightly volatile
Cost Of Revenue193.9 M184.7 M99.8 M
Slightly volatile
Total Operating Expenses422.8 M402.6 M212.7 M
Slightly volatile
Non Recurring2.4 M2.7 M3 M
Slightly volatile
Selling And Marketing Expenses106.6 M153 M88.7 M
Slightly volatile
Interest Income5.8 M10.8 M5.9 M
Pretty Stable
Reconciled Depreciation91.9 M87.5 M29.8 M
Slightly volatile

Pacira BioSciences, Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation26.4 M47.9 M27.3 M
Slightly volatile
Begin Period Cash Flow89.8 M104.1 M91.8 M
Slightly volatile
Depreciation79.4 M75.6 M26.4 M
Slightly volatile
Capital Expenditures21.7 M15.2 M21.7 M
Slightly volatile
End Period Cash Flow99.9 M153.3 M101.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.192.31057.3785
Slightly volatile
Dividend Yield0.00140.00120.0019
Slightly volatile
PTB Ratio1.71.79238.3333
Slightly volatile
Days Sales Outstanding37.4257.080348.0316
Very volatile
Book Value Per Share19.7718.8259.8217
Slightly volatile
Stock Based Compensation To Revenue0.07210.0710.0985
Slightly volatile
Capex To Depreciation0.190.20061.5561
Slightly volatile
PB Ratio1.71.79238.3333
Slightly volatile
Inventory Turnover1.681.76973.3382
Slightly volatile
Days Of Inventory On Hand119206160
Slightly volatile
Payables Turnover7.2311.76399.8707
Pretty Stable
Sales General And Administrative To Revenue0.330.17250.3685
Slightly volatile
Research And Ddevelopement To Revenue0.110.1130.3563
Slightly volatile
Capex To Revenue0.02130.02250.1462
Slightly volatile
Cash Per Share8.936.0278.3282
Very volatile
Days Payables Outstanding29.4831.027252.3729
Slightly volatile
Intangibles To Total Assets0.430.41060.1973
Slightly volatile
Current Ratio5.55.2373.6332
Slightly volatile
Receivables Turnover9.036.39457.8601
Very volatile
Graham Number37.6519.607723.4679
Pretty Stable
Shareholders Equity Per Share19.7718.8259.8217
Slightly volatile
Capex Per Share0.310.3281.2758
Slightly volatile
Revenue Per Share10.6614.6039.2427
Pretty Stable
Interest Debt Per Share12.3311.74218.0817
Slightly volatile
Debt To Assets0.30.33180.3625
Pretty Stable
Operating Cycle156263208
Slightly volatile
Price Book Value Ratio1.71.79238.3333
Slightly volatile
Days Of Payables Outstanding29.4831.027252.3729
Slightly volatile
Company Equity Multiplier1.631.80942.5091
Slightly volatile
Quick Ratio2.244.16542.9694
Pretty Stable
Net Income Per E B T1.170.681.3973
Pretty Stable
Cash Ratio1.241.57421.145
Very volatile
Days Of Inventory Outstanding119206160
Slightly volatile
Days Of Sales Outstanding37.4257.080348.0316
Very volatile
Price To Book Ratio1.71.79238.3333
Slightly volatile
Fixed Asset Turnover1.632.87292.1877
Slightly volatile
Debt Ratio0.30.33180.3625
Pretty Stable
Price Sales Ratio2.192.31057.3785
Slightly volatile
Asset Turnover0.340.42870.4284
Very volatile
Price Fair Value1.71.79238.3333
Slightly volatile

Pacira BioSciences, Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.7 B1.6 B1.5 B
Slightly volatile

Pacira Fundamental Market Drivers

Forward Price Earnings4.852
Cash And Short Term Investments278.6 M

Pacira Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Pacira BioSciences, Financial Statements

Pacira BioSciences, investors use historical fundamental indicators, such as Pacira BioSciences,'s revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue39.1 M41.1 M
Total Revenue675 M708.7 M
Cost Of Revenue184.7 M193.9 M
Stock Based Compensation To Revenue 0.07  0.07 
Sales General And Administrative To Revenue 0.17  0.33 
Research And Ddevelopement To Revenue 0.11  0.11 
Capex To Revenue 0.02  0.02 
Revenue Per Share 14.60  10.66 
Ebit Per Revenue 0.13  0.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY